Table I.
Clinical parameters in patients with HCM and control subjects.
| Parameters | HCM (n=42) | Control (n=40) | P-value |
|---|---|---|---|
| Age (years) | 53.74±12.98 | 50.56±12.93 | 0.319 |
| Sex (M/F) | 20/11 | 16/20 | 0.081 |
| Heart rate | 68.52±10.49 | 68.52±10.49 | 0.198 |
| BMI (kg/m2) | 25.67±3.96 | 23.58±2.94 | 0.026 |
| BSA (m2) | 1.79±0.18 | 1.64±0.15 | 0.002 |
| SBP (mmHg) | 132±13 | 115±12 | 0.028 |
| DBP (mmHg) | 87±10 | 74±9 | 0.051 |
| Cho (mmol/l) | 4.227±1.132 | 4.650±0.878 | 0.163 |
| TG (mmol/l) | 1.402±0.654 | 1.459±0.416 | 0.7154 |
| LDL-C (mmol/l) | 2.685±1.063 | 2.683±0.914 | 0.993 |
| HDL-C (mmol/l) | 1.127±0.203 | 1.301±0.379 | 0.124 |
Values were shown as the mean ± standard deviation. HCM, hypertrophic cardiomyopathy; BMI, body mass index; BSA, body surface area; SBP, systolic blood pressure; DBP, diastolic blood pressure; Cho, cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.